Abstract
The authors present results of using recombinant human erythropoietin in patients operated on the heart under conditions of extracorporeal blood circulation. It was found that the intravenous infusions of erythropoietin at the postoperative period accelerated the restitution of circulating erythron indices. The volume of transfusion of the donor erythrocyte-containing media to the patient is given erythropoietin was reliably less than that in the control group. The results obtained allow using erythropoietin to be recommended as an effective method of prophylactics and treatment of anemia in cardiosurgical patients.
Publication types
-
Clinical Trial
-
English Abstract
MeSH terms
-
Adult
-
Anemia / blood
-
Anemia / drug therapy
-
Anemia / prevention & control*
-
Cardiac Surgical Procedures*
-
Endocarditis, Bacterial / blood
-
Endocarditis, Bacterial / surgery
-
Erythropoietin / therapeutic use*
-
Extracorporeal Circulation
-
Female
-
Heart Defects, Congenital / blood
-
Heart Defects, Congenital / surgery
-
Humans
-
Hypothermia, Induced
-
Male
-
Postoperative Care
-
Postoperative Complications / blood
-
Postoperative Complications / drug therapy
-
Postoperative Complications / prevention & control*
-
Recombinant Proteins
-
Rheumatic Heart Disease / blood
-
Rheumatic Heart Disease / surgery
Substances
-
Recombinant Proteins
-
Erythropoietin